Fibrosis
3
Pipeline Programs
4
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
DebiopharmEPI-hNE4
Liminal BioSciencesPBI-4050/ Placebo
Bristol Myers SquibbND-L02-s0201
Clinical Trials (3)
Total enrollment: 12 patients across 3 trials
Safety and Efficacy Study of Depelestat in Acute Respiratory Distress Syndrome (ARDS) Patients
Start: Jul 2006Est. completion: Sep 2007
Phase 2Completed
A Healthy Volunteer Study of PBI-4050
Start: Dec 2020Est. completion: Oct 2021
Phase 1Completed
A Study of Safety, Tolerability, and the Effects Two ND-L02-s0201 Have on the Body
Start: Aug 2016Est. completion: Oct 201612 patients
Phase 1Completed
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
4 companies competing in this space